PRKN and Venous thrombosis: Further, platelet-lymphocyte aggregates are associated with increased thrombosis risk28, and venous thrombosis is a cause of sudden death in PD29, suggesting targeting the Pink1/Parkin pathway in the periphery has therapeutic potential.